Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$377K Buy
4,455
+220
+5% +$17.7K 0.03% 388
2026
Q1
$300K Buy
4,235
+208
+5% +$15.6K 0.02% 424
2025
Q4
$318K Sell
4,027
-282
-7% -$22.3K 0.03% 369
2025
Q3
$355K Buy
4,309
+87
+2% +$6.85K 0.03% 340
2025
Q2
$340K Sell
4,222
-179
-4% -$13.8K 0.03% 328
2025
Q1
$353K Buy
4,401
+61
+1% +$5.07K 0.04% 295
2024
Q4
$355K Buy
4,340
+40
+0.9% +$3.33K 0.04% 285
2024
Q3
$355K Buy
4,300
+151
+4% +$11.3K 0.04% 292
2024
Q2
$291K Sell
4,149
-654
-14% -$46.7K 0.03% 310
2024
Q1
$356K Buy
+4,803
New +$335K 0.04% 283

Other funds holding MET

Advisor OS's MET Position: Q2 2026 in Review

Advisor OS increased its MetLife (MET) stake by 5.2% in Q2 2026, buying an estimated $17.7K and bringing the position to 4,455 shares worth $377K. The position accounts for 0.03% of the portfolio, ranked #388.

Advisor OS first reported a position in MET in Q1 2024 and has held it in 10 quarters since. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Advisor OS held 4,455 shares of MetLife worth $377K as of Q2 2026.
  • Advisor OS bought 220 MetLife shares in Q2 2026, an estimated $17.7K.
  • MetLife made up 0.03% of Advisor OS's portfolio in Q2 2026, its #388 holding.
  • Advisor OS first reported a position in MetLife in Q1 2024 and has held it in 10 quarters since.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Advisor OS's 13F filing for Q2 2026, filed 5 Aug 2026.